Bellus: 3Q Earnings Snapshot

November 14, 2019

LAVAL, Quebec (AP) _ Bellus Health Inc. (BLU) on Thursday reported a loss of $6.5 million in its third quarter.

The Laval, Quebec-based company said it had a loss of 14 cents per share.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.

The drug developer posted revenue of $6,800 in the period. Its adjusted revenue was $7,000, matching Street forecasts.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLU at https://www.zacks.com/ap/BLU